FDA Approved: ROCKLATAN — Original Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved ROCKLATAN as an original application for a fixed-dose combination ophthalmic solution of netarsudil 0.02% and latanoprost 0.005% to lower intra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

ORIG AP for ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%)